The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Potential Therapeutic Targets of Rehmannia Formulations on Diabetic Nephropathy: A Comparative Network Pharmacology Analysis
|
---|---|
Published in |
Frontiers in Pharmacology, March 2022
|
DOI | 10.3389/fphar.2022.794139 |
Pubmed ID | |
Authors |
Kam Wa Chan, Kam Yan Yu, Wai Han Yiu, Rui Xue, Sarah Wing-yan Lok, Hongyu Li, Yixin Zou, Jinyuan Ma, Kar Neng Lai, Sydney Chi-wai Tang |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Hong Kong | 1 | 20% |
Unknown | 4 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Science communicators (journalists, bloggers, editors) | 1 | 20% |
Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 11 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 1 | 9% |
Student > Bachelor | 1 | 9% |
Researcher | 1 | 9% |
Student > Doctoral Student | 1 | 9% |
Student > Master | 1 | 9% |
Other | 0 | 0% |
Unknown | 6 | 55% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 2 | 18% |
Unspecified | 1 | 9% |
Immunology and Microbiology | 1 | 9% |
Biochemistry, Genetics and Molecular Biology | 1 | 9% |
Unknown | 6 | 55% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 June 2024.
All research outputs
#15,698,047
of 26,557,556 outputs
Outputs from Frontiers in Pharmacology
#5,051
of 20,601 outputs
Outputs of similar age
#207,466
of 453,958 outputs
Outputs of similar age from Frontiers in Pharmacology
#287
of 1,284 outputs
Altmetric has tracked 26,557,556 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,601 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,958 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 1,284 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.